- Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy2017 | First Faculty of Medicine, Second Faculty of Medicine
- Immunotherapy in small cell lung cancer2021 | Faculty of Medicine in Pilsen
- Immunotherapy in lung cancer treatment2016 | Publication without faculty affiliation
- Atypical response to anti-PD-1 therapy followed by long-term survival in non-small cell lung cancer - case reports2020 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Atezolizumab in the treatment of lung cancer2020 | Publication without faculty affiliation
- Immunotherapy of small cell lung cancer2020 | Publication without faculty affiliation
- Durvalumab in the treatment of lung cancer2019 | Second Faculty of Medicine
- Immunotherapy in the first line treatment of non-small cell lung cancer2020 | Faculty of Medicine in Pilsen
- Nivolumab as second-line therapy for patients with advanced NSCLC (non-small cell lung cancer)2022 | First Faculty of Medicine
- Immunotherapy in the first line treatment of non-small cell lung cancer2021 | Publication without faculty affiliation
- Complete response to pembrolizumab in a patient with stage IV NSCLC (non-small cell lung cancer)2020 | First Faculty of Medicine
- High hydrostatic pressure affects antigenic pool in tumor cells: Implication for dendritic cell-based cancer immunotherapy2017 | Second Faculty of Medicine
- Lung cancer on virtual ASCO 20212021 | Publication without faculty affiliation
- Fecal microbiota transplantation - new possibility to influence the results of therapy of cancer patients2022 | First Faculty of Medicine, Second Faculty of Medicine
- Non-small-cell lung cancer - koncertant diagnostic and therapeutic news2016 | Faculty of Medicine in Pilsen
- Detection of tumor antigens and tumor-antigen specific T cells in NSCLC patients: Correlation of the quality of T cell responses with NSCLC subtype2020 | First Faculty of Medicine, Second Faculty of Medicine